{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:29:59Z","timestamp":1794857399714,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["Intramural funds"],"award-info":[{"award-number":["Intramural funds"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA78527"],"award-info":[{"award-number":["CA78527"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA238592"],"award-info":[{"award-number":["CA238592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Invasive cervical cancers (ICC), caused by HPV infections, have a heterogeneous molecular landscape. We investigate the detection, timing, and HPV type specificity of somatic mutations in 3929 HPV-positive exfoliated cervical cell samples from individuals undergoing cervical screening in the U.S. using deep targeted sequencing in ICC cases, precancers, and HPV-positive controls. We discover a subset of hotspot mutations rare in controls (2.6%) but significantly more prevalent in precancers, particularly glandular precancer lesions (10.2%), and cancers (25.7%), supporting their involvement in ICC carcinogenesis. Hotspot mutations differ by HPV type, and HPV18\/45-positive ICC are more likely to have multiple hotspot mutations compared to HPV16-positive ICC. The proportion of cells containing hotspot mutations is higher (i.e., higher variant allele fraction) in ICC and mutations are detectable up to 6\u2009years prior to cancer diagnosis. Our findings demonstrate the feasibility of using exfoliated cervical cells for detection of somatic mutations as potential diagnostic biomarkers.<\/jats:p>","DOI":"10.1038\/s41467-024-51713-y","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:05:55Z","timestamp":1726243555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Somatic mutations in 3929 HPV positive cervical cells associated with infection outcome and HPV type"],"prefix":"10.1038","volume":"15","author":[{"given":"Maisa","family":"Pinheiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2234-0631","authenticated-orcid":false,"given":"Michael","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3871-2225","authenticated-orcid":false,"given":"Meredith","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8866-2357","authenticated-orcid":false,"given":"Amulya","family":"Shastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Burdett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8319-0599","authenticated-orcid":false,"given":"Sambit","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-8458","authenticated-orcid":false,"given":"Robert D.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0172-5516","authenticated-orcid":false,"given":"Bin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-0106","authenticated-orcid":false,"given":"Lisa","family":"Mirabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"51713_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"51713_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.86","volume":"2","author":"M Schiffman","year":"2016","unstructured":"Schiffman, M. et al. Carcinogenic human papillomavirus infection. Nat. Rev. Dis. Primers 2, 16086 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"51713_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cell.2018.03.042","volume":"173","author":"C Hutter","year":"2018","unstructured":"Hutter, C. & Zenklusen, J. C. The cCancer genome Atlas: creating lasting value beyond its data. Cell 173, 283\u2013285 (2018).","journal-title":"Cell"},{"key":"51713_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature21386","volume":"543","author":"N Cancer Genome Atlas Research","year":"2017","unstructured":"Cancer Genome Atlas Research, N. et al. Integrated genomic and molecular characterization of cervical cancer. Nature 543, 378\u2013384 (2017).","journal-title":"Nature"},{"key":"51713_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12881","volume":"506","author":"AI Ojesina","year":"2014","unstructured":"Ojesina, A. I. et al. Landscape of genomic alterations in cervical carcinomas. Nature 506, 371\u2013375 (2014).","journal-title":"Nature"},{"key":"51713_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41588-020-0673-7","volume":"52","author":"A Gagliardi","year":"2020","unstructured":"Gagliardi, A. et al. Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. Nat. Genet. 52, 800\u2013810 (2020).","journal-title":"Nat. Genet."},{"key":"51713_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-6-229","volume":"9","author":"SG Conticello","year":"2008","unstructured":"Conticello, S. G. The AID\/APOBEC family of nucleic acid mutators. Genome Biol. 9, 229 (2008).","journal-title":"Genome Biol."},{"key":"51713_CR8","doi-asserted-by":"crossref","unstructured":"Warren, C. J., Westrich, J. A., Doorslaer, K. V. & Pyeon, D. Roles of APOBEC3A and APOBEC3B in human papillomavirus infection and disease progression. Viruses 9, 233 (2017).","DOI":"10.3390\/v9080233"},{"key":"51713_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/ng.3378","volume":"47","author":"K Chan","year":"2015","unstructured":"Chan, K. et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat. Genet. 47, 1067\u20131072 (2015).","journal-title":"Nat. Genet."},{"key":"51713_CR10","doi-asserted-by":"publisher","DOI":"10.1515\/med-2023-0759","volume":"18","author":"M Niyazi","year":"2023","unstructured":"Niyazi, M. et al. Analysis of somatic mutations and key driving factors of cervical cancer progression. Open Med. (Wars) 18, 20230759 (2023).","journal-title":"Open Med. (Wars)"},{"key":"51713_CR11","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1158\/1078-0432.CCR-14-1837","volume":"21","author":"H Lou","year":"2015","unstructured":"Lou, H. et al. Genome analysis of Latin American cervical cancer: frequent activation of the PIK3CA pathway. Clin. Cancer Res. 21, 5360\u20135370 (2015).","journal-title":"Clin. Cancer Res."},{"key":"51713_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1128\/JVI.02383-14","volume":"89","author":"CJ Warren","year":"2015","unstructured":"Warren, C. J. et al. APOBEC3A functions as a restriction factor of human papillomavirus. J. Virol. 89, 688\u2013702 (2015).","journal-title":"J. Virol."},{"key":"51713_CR13","doi-asserted-by":"publisher","first-page":"e72565","DOI":"10.1371\/journal.pone.0072565","volume":"8","author":"Z Chen","year":"2013","unstructured":"Chen, Z. et al. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS One 8, e72565 (2013).","journal-title":"PLoS One"},{"key":"51713_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","volume":"401","author":"HU Bernard","year":"2010","unstructured":"Bernard, H. U. et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401, 70\u201379 (2010).","journal-title":"Virology"},{"key":"51713_CR15","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose, S. et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 11, 1048\u20131056 (2010).","journal-title":"Lancet Oncol."},{"key":"51713_CR16","first-page":"13","volume":"186","author":"H Delius","year":"1994","unstructured":"Delius, H. & Hofmann, B. Primer-directed sequencing of human papillomavirus types. Curr. Top Microbiol. Immunol. 186, 13\u201331 (1994).","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"51713_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","volume":"445","author":"RD Burk","year":"2013","unstructured":"Burk, R. D., Harari, A. & Chen, Z. Human papillomavirus genome variants. Virology 445, 232\u2013243 (2013).","journal-title":"Virology"},{"key":"51713_CR18","doi-asserted-by":"publisher","first-page":"djw100","DOI":"10.1093\/jnci\/djw100","volume":"108","author":"L Mirabello","year":"2016","unstructured":"Mirabello, L. et al. HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women. J. Natl. Cancer Inst. 108, djw100 (2016).","journal-title":"J. Natl. Cancer Inst."},{"key":"51713_CR19","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2017.08.001","volume":"170","author":"L Mirabello","year":"2017","unstructured":"Mirabello, L. et al. HPV16 E7 genetic conservation is critical to carcinogenesis. Cell 170, 1164\u20131174 e1166 (2017).","journal-title":"Cell"},{"key":"51713_CR20","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","volume":"22","author":"M Arbyn","year":"2011","unstructured":"Arbyn, M. et al. Worldwide burden of cervical cancer in 2008. Ann. Oncol. 22, 2675\u20132686 (2011).","journal-title":"Ann. Oncol."},{"key":"51713_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ygyno.2023.05.011","volume":"174","author":"M Schiffman","year":"2023","unstructured":"Schiffman, M. et al. The combined finding of HPV 16, 18, or 45 and cytologic atypical glandular cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma. Gynecol. Oncol. 174, 253\u2013261 (2023).","journal-title":"Gynecol. Oncol."},{"key":"51713_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1158\/0008-5472.CAN-07-2754","volume":"68","author":"S Vinokurova","year":"2008","unstructured":"Vinokurova, S. et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res. 68, 307\u2013313 (2008).","journal-title":"Cancer Res."},{"key":"51713_CR23","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41586-020-2214-z","volume":"580","author":"L Moore","year":"2020","unstructured":"Moore, L. et al. The mutational landscape of normal human endometrial epithelium. Nature 580, 640\u2013646 (2020).","journal-title":"Nature"},{"key":"51713_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029\u20131041 e1021 (2017).","journal-title":"Cell"},{"key":"51713_CR25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.aav5697","volume":"362","author":"SJ Chanock","year":"2018","unstructured":"Chanock, S. J. The paradox of mutations and cancer. Science 362, 893\u2013894 (2018).","journal-title":"Science"},{"key":"51713_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/dc.24511","volume":"48","author":"T Yamaguchi","year":"2020","unstructured":"Yamaguchi, T. et al. Next-generation sequencing in residual liquid-based cytology specimens for cancer genome analysis. Diagn Cytopathol. 48, 965\u2013971 (2020).","journal-title":"Diagn Cytopathol."},{"key":"51713_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","volume":"578","author":"M Gerstung","year":"2020","unstructured":"Gerstung, M. et al. The evolutionary history of 2,658 cancers. Nature 578, 122\u2013128 (2020).","journal-title":"Nature"},{"key":"51713_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1126\/science.aau3879","volume":"362","author":"I Martincorena","year":"2018","unstructured":"Martincorena, I. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911\u2013917 (2018).","journal-title":"Science"},{"key":"51713_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"51713_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14730-1","volume":"11","author":"B Zhu","year":"2020","unstructured":"Zhu, B. et al. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat. Commun. 11, 886 (2020).","journal-title":"Nat. Commun."},{"key":"51713_CR31","doi-asserted-by":"crossref","unstructured":"Faden, D. L. et al. APOBEC mutagenesis is concordant between tumor and viral genomes in HPV-positive head and neck Squamous cell carcinoma. Viruses 13, 1666 (2021).","DOI":"10.3390\/v13081666"},{"key":"51713_CR32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1158\/1055-9965.EPI-10-1267","volume":"20","author":"PE Castle","year":"2011","unstructured":"Castle, P. E. et al. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at kaiser permanente Northern California. Cancer Epidemiol .Biomarkers Prev. 20, 946\u2013953 (2011).","journal-title":"Cancer Epidemiol .Biomarkers Prev."},{"key":"51713_CR33","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/infdis\/174.4.679","volume":"174","author":"RD Burk","year":"1996","unstructured":"Burk, R. D. et al. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J. Infect. Dis. 174, 679\u2013689 (1996).","journal-title":"J. Infect. Dis."},{"key":"51713_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6, 80\u201392 (2012).","journal-title":"Fly (Austin)"},{"key":"51713_CR35","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"51713_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"51713_CR37","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"51713_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0531-8","volume":"10","author":"D Tamborero","year":"2018","unstructured":"Tamborero, D. et al. Cancer genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med. 10, 25 (2018).","journal-title":"Genome Med."},{"key":"51713_CR39","doi-asserted-by":"publisher","first-page":"e1006981","DOI":"10.1371\/journal.pcbi.1006981","volume":"15","author":"AL Brown","year":"2019","unstructured":"Brown, A. L., Li, M., Goncearenco, A. & Panchenko, A. R. Finding driver mutations in cancer: elucidating the role of background mutational processes. PLoS Comput. Biol. 15, e1006981 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"51713_CR40","doi-asserted-by":"publisher","first-page":"W514","DOI":"10.1093\/nar\/gkx367","volume":"45","author":"A Goncearenco","year":"2017","unstructured":"Goncearenco, A. et al. Exploring background mutational processes to decipher cancer genetic heterogeneity. Nucleic Acids Res. 45, W514\u2013W522 (2017).","journal-title":"Nucleic Acids Res."},{"key":"51713_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"51713_CR42","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal 6, pl1 (2013).","journal-title":"Sci. Signal"},{"key":"51713_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cels.2019.05.005","volume":"9","author":"C Tokheim","year":"2019","unstructured":"Tokheim, C. & Karchin, R. CHASMplus reveals the scope of somatic missense mutations driving human cancers. Cell Syst. 9, 9\u201323 e28 (2019).","journal-title":"Cell Syst."},{"key":"51713_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"51713_CR45","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","volume":"77","author":"JT Robinson","year":"2017","unstructured":"Robinson, J. T., Thorvaldsd\u00f3ttir, H., Wenger, A. M., Zehir, A. & Mesirov, J. P. Variant review with the integrative genomics viewer. Cancer Res. 77, e31\u2013e34 (2017).","journal-title":"Cancer Res."},{"key":"51713_CR46","doi-asserted-by":"crossref","unstructured":"Pinheiro, M. et al. Phylogenomic analysis of human papillomavirus Type 31 and cervical carcinogenesis: a study of 2093 viral genomes. Viruses 13, 1948 (2021).","DOI":"10.3390\/v13101948"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51713-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51713-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51713-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:08:05Z","timestamp":1726243685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51713-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51713"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51713-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.P. is currently an employee of GlaxoSmithKline, J.F.B. and S.B. are now employees of AstraZeneca, and Amulya Shastry is now a doctoral student at Boston University, but they all completed the work associated with this project while employed at the National Cancer Institute. P.E.C. has received HPV tests and assays at a reduced or no cost for research from Roche, Becton Dickinson, Cepheid and Arbor Vita Corporation. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7895"}}